GPR50 (mtr1l_human)
FAMILY
Class A (Rhodopsin) Orphan receptors Class A orphans GPR50
GENE
GPR50
ORGANISM
Human (Homo sapiens)
ALT. NAMES
Melatonin-related receptor, G protein-coupled receptor 50, H9
SOURCE
SWISSPROT
SEQUENCE
N-term | |||||||||
M
|
G
|
P
|
T
|
L
|
A
|
V
|
P
|
T
|
P
|
10 |
Y
|
G
|
C
|
I
|
G
|
C
|
K
|
L
|
P
|
Q
|
20 |
TM1 | |||||||||
P
|
E
|
Y
|
P
|
P
|
A
|
L
|
I
|
I
|
F
|
30 |
M
|
F
|
C
|
A
|
M
|
V
|
I
|
T
|
I
|
V
|
40 |
V
|
D
|
L
|
I
|
G
|
N
|
S
|
M
|
V
|
I
|
50 |
ICL1 | |||||||||
L
|
A
|
V
|
T
|
K
|
N
|
K
|
K
|
L
|
R
|
60 |
TM2 | |||||||||
N
|
S
|
G
|
N
|
I
|
F
|
V
|
V
|
S
|
L
|
70 |
S
|
V
|
A
|
D
|
M
|
L
|
V
|
A
|
I
|
Y
|
80 |
P
|
Y
|
P
|
L
|
M
|
L
|
H
|
A
|
M
|
S
|
90 |
ECL1 | TM3 | ||||||||
I
|
G
|
G
|
W
|
D
|
L
|
S
|
Q
|
L
|
Q
|
100 |
C
|
Q
|
M
|
V
|
G
|
F
|
I
|
T
|
G
|
L
|
110 |
S
|
V
|
V
|
G
|
S
|
I
|
F
|
N
|
I
|
V
|
120 |
A
|
I
|
A
|
I
|
N
|
R
|
Y
|
C
|
Y
|
I
|
130 |
ICL2 | |||||||||
C
|
H
|
S
|
L
|
Q
|
Y
|
E
|
R
|
I
|
F
|
140 |
TM4 | |||||||||
S
|
V
|
R
|
N
|
T
|
C
|
I
|
Y
|
L
|
V
|
150 |
I
|
T
|
W
|
I
|
M
|
T
|
V
|
L
|
A
|
V
|
160 |
L
|
P
|
N
|
M
|
Y
|
I
|
G
|
T
|
I
|
E
|
170 |
ECL2 | |||||||||
Y
|
D
|
P
|
R
|
T
|
Y
|
T
|
C
|
I
|
F
|
180 |
TM5 | |||||||||
N
|
Y
|
L
|
N
|
N
|
P
|
V
|
F
|
T
|
V
|
190 |
T
|
I
|
V
|
C
|
I
|
H
|
F
|
V
|
L
|
P
|
200 |
L
|
L
|
I
|
V
|
G
|
F
|
C
|
Y
|
V
|
R
|
210 |
I
|
W
|
T
|
K
|
V
|
L
|
A
|
A
|
R
|
D
|
220 |
ICL3 | TM6 | ||||||||
P
|
A
|
G
|
Q
|
N
|
P
|
D
|
N
|
Q
|
L
|
230 |
A
|
E
|
V
|
R
|
N
|
F
|
L
|
T
|
M
|
F
|
240 |
V
|
I
|
F
|
L
|
L
|
F
|
A
|
V
|
C
|
W
|
250 |
C
|
P
|
I
|
N
|
V
|
L
|
T
|
V
|
L
|
V
|
260 |
ECL3 | |||||||||
A
|
V
|
S
|
P
|
K
|
E
|
M
|
A
|
G
|
K
|
270 |
TM7 | |||||||||
I
|
P
|
N
|
W
|
L
|
Y
|
L
|
A
|
A
|
Y
|
280 |
F
|
I
|
A
|
Y
|
F
|
N
|
S
|
C
|
L
|
N
|
290 |
H8 | |||||||||
A
|
V
|
I
|
Y
|
G
|
L
|
L
|
N
|
E
|
N
|
300 |
F
|
R
|
R
|
E
|
Y
|
W
|
T
|
I
|
F
|
H
|
310 |
C-term | |||||||||
A
|
M
|
R
|
H
|
P
|
I
|
I
|
F
|
F
|
S
|
320 |
G
|
L
|
I
|
S
|
D
|
I
|
R
|
E
|
M
|
Q
|
330 |
E
|
A
|
R
|
T
|
L
|
A
|
R
|
A
|
R
|
A
|
340 |
H
|
A
|
R
|
D
|
Q
|
A
|
R
|
E
|
Q
|
D
|
350 |
R
|
A
|
H
|
A
|
C
|
P
|
A
|
V
|
E
|
E
|
360 |
T
|
P
|
M
|
N
|
V
|
R
|
N
|
V
|
P
|
L
|
370 |
P
|
G
|
D
|
A
|
A
|
A
|
G
|
H
|
P
|
D
|
380 |
R
|
A
|
S
|
G
|
H
|
P
|
K
|
P
|
H
|
S
|
390 |
R
|
S
|
S
|
S
|
A
|
Y
|
R
|
K
|
S
|
A
|
400 |
S
|
T
|
H
|
H
|
K
|
S
|
V
|
F
|
S
|
H
|
410 |
S
|
K
|
A
|
A
|
S
|
G
|
H
|
L
|
K
|
P
|
420 |
V
|
S
|
G
|
H
|
S
|
K
|
P
|
A
|
S
|
G
|
430 |
H
|
P
|
K
|
S
|
A
|
T
|
V
|
Y
|
P
|
K
|
440 |
P
|
A
|
S
|
V
|
H
|
F
|
K
|
A
|
D
|
S
|
450 |
V
|
H
|
F
|
K
|
G
|
D
|
S
|
V
|
H
|
F
|
460 |
K
|
P
|
D
|
S
|
V
|
H
|
F
|
K
|
P
|
A
|
470 |
S
|
S
|
N
|
P
|
K
|
P
|
I
|
T
|
G
|
H
|
480 |
H
|
V
|
S
|
A
|
G
|
S
|
H
|
S
|
K
|
S
|
490 |
A
|
F
|
S
|
A
|
A
|
T
|
S
|
H
|
P
|
K
|
500 |
P
|
T
|
T
|
G
|
H
|
I
|
K
|
P
|
A
|
T
|
510 |
S
|
H
|
A
|
E
|
P
|
T
|
T
|
A
|
D
|
Y
|
520 |
P
|
K
|
P
|
A
|
T
|
T
|
S
|
H
|
P
|
K
|
530 |
P
|
T
|
A
|
A
|
D
|
N
|
P
|
E
|
L
|
S
|
540 |
A
|
S
|
H
|
C
|
P
|
E
|
I
|
P
|
A
|
I
|
550 |
A
|
H
|
P
|
V
|
S
|
D
|
D
|
S
|
D
|
L
|
560 |
P
|
E
|
S
|
A
|
S
|
S
|
P
|
A
|
A
|
G
|
570 |
P
|
T
|
K
|
P
|
A
|
A
|
S
|
Q
|
L
|
E
|
580 |
S
|
D
|
T
|
I
|
A
|
D
|
L
|
P
|
D
|
P
|
590 |
T
|
V
|
V
|
T
|
T
|
S
|
T
|
N
|
D
|
Y
|
600 |
H
|
D
|
V
|
V
|
V
|
I
|
D
|
V
|
E
|
D
|
610 |
D
|
P
|
D
|
E
|
M
|
A
|
V
|
LINKS
DIAGRAMS
Pick color:
Invitro Mutant Data: Increased binding/potency: >5-fold, >10-fold; Reduced binding/potency: >5-fold, >10-fold; No/low effect (<5-fold); and N/A
Pick color:
Invitro Mutant Data: Increased binding/potency: >5-fold, >10-fold; Reduced binding/potency: >5-fold, >10-fold; No/low effect (<5-fold); and N/A
MUTATIONS
PHYSIOLOGICAL LIGANDS
No physiological ligands available
STRUCTURE MODELS
STRUCTURES
No structures available